4TH SYMPOSIUM on
RELATIVITY IN THE EVALUATION OF MEDICINES
at The London Renaissance Hotel
.
Thursday, 13 February 2014
TO CONFIRM YOUR ATTENDANCE PLEASE REGISTER TODAY |
Join the debate with industry leaders to discuss
Timely Evidence from development to Real World
Confirmed programme speakers:
- Dr. Tomas Salmonson, Chairman, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA)
- Prof. Jean-Luc Harousseau, Chairman of the Board, Haute Autorit de Sant (HAS), France
- Dr. Finn Borlum Kristensen, General Director, European Network for Health Technology Assessment (EUnetHTA), Denmark
- Dr. Dominique Giorgi, President, President du Comite Economique des Produits de Sante (CEPS), France
-
Dr. Peter Arlett Head of Pharmacovigilance and Risk Management Sector, EMA
- Prof. Luca Pani, General Director, Italian Medicines Agency
- Dr. Richard Bergstrom, General Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
- Dr. Spiros Vamvakas, Early Scientific Advice EMA/HTA, European Medicines Association (EMA),United Kingdom
-
Dr. Alric Alf Ruether Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Germany
- Dr. Andrzej Rys, Director for Health Systems and Products, European Commission
- Sir Andrew Dillon, Chief Executive of National Institute for Health Care and Excellence (NICE), United Kingdom
- Prof. Lucien Abenhaim, Chairman, LA-SER and Honorary Professor, London. School of Hygiene & Tropical Medicine, United Kingdom
Please visit www.laser-symposium.com for latest agenda
Payment is accepted via the registration website PayPal, or via bank transfer or cheque. Pre-payment is not required for registration - this can be made at a later date.
- 750.00 EUR - Registration fee